The company plans to continue developing different types of plug-ins for customers. Flow cytometry was thrust into the spotlight by the AIDS epidemic in the 1980s as it provides a quick and ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...
“Flow cytometry gives clinically important and ... labelled with a broad selection of markers for many uses. The company produces synthetic white blood cells to replace their biological ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...
Spectral flow cytometry collects the full emission spectrum of a fluorochrome ... TBUSH”) today announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.